$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000709 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000708 Size: 9 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001683168-24-000660 Act: 34 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001683168-24-000580 Act: 33 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000237 Act: 33 Size: 1 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 5.02 Accession Number: 0001683168-24-000393 Act: 34 Size: 202 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-000358 Act: 33 Size: 4 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-000182 Act: 33 Size: 3 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 7.01 Accession Number: 0001683168-23-009006 Act: 34 Size: 201 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001683168-23-008901 Act: 34 Size: 230 KB 网页链接